logo

For the Inventor, By the Inventor

O'Fallon, MO, United States of America

Michael B Tollefson

This inventor holds 45 USPTO granted patents, primarily in Cholesterol Inhibitors. Top assignees: Pharmacia Corporation, G.d. Searle & Company, Pfizer Corporation. Active years: 2002-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael B Tollefson. Retrieved from https://idiyas.com/inventor/michael-b-tollefson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 45

% Patents Active = 4.4

Average Co-Inventor Count = 12.2

ph-index = 8

Forward Citations = 233(Granted Patents)


Location History:

  • O'Fallon, MI (US) (2004)
  • Hainesville, IL (US) (2004 - 2007)
  • O'Fallon, MO (US) (2002 - 2010)
  • Dardenne Prairie, MO (US) (2011 - 2013)

Company Filing History:

goldMedal24 out of 220 
 
Pharmacia Corporation
 patents
silverMedal12 out of 1,323 
 
G.d. Searle & Company
 patents
bronzeMedal6 out of 4,492 
 
Pfizer Corporation
 patents
4. 2 out of 523 
 
Pharmacia & Upjohn Company
 patents
5. 1 out of 1 
 
Pharmacia Corporation Global Patent Department
 patent

Years Active: 2002-2013

Loading Chart...
Areas of Expertise:
Cholesterol Ester Transfer Protein
Pyrazole Derivatives
Integrin Receptor Antagonists
Heterocyclic Compounds
Amino Alcohols
Metalloprotease Inhibitors
Sulfone Hydroxamic Acids
Anti-Inflammatory Agents
Aromatic Compounds
Heteroaryl Compounds
Reverse Aminoalcohols
Cycloalkyl Aminoalcohols
45 patents (USPTO):Explore Patents
1. 8518956 - [object Object] (2013-08-27),
2. 8097733 - Pyrazole derivatives as 5-LO-inhibitors (2012-01-17),
3. 7902195 - Pyridine [3,4-b] pyrazinones (2011-03-08),
4. 7700658 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2010-04-20),
5. 7253211 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2007-08-07),
6. 7186743 - Substituted pyrazolyl compounds for the treatment of inflammation (2007-03-06),
7. 7122536 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2006-10-17),
8. 7119098 - Heteroarylakanoic acids as intergrin receptor antagonists (2006-10-10),
9. 6956052 - Substituted pyrazolyl compounds for the treatment of inflammation (2005-10-18),
10. 6933304 - Heteroarylalkanoic acids as integrin receptor antagonists (2005-08-23),
11. 6828446 - Aromatic thioether liver X-receptor modulators (2004-12-07),
12. 6803388 - (R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-10-12),
13. 6765023 - Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-07-20),
14. 6750233 - Aromatic sulfone hydroxamic acid metalloprotease inhibitor (2004-06-15),
15. 6750228 - Aromatic sulfone hydroxamic acid metalloprotease inhibitor (2004-06-15),

Title: Inventor Michael B Tollefson - Pioneering Innovations in O'Fallon

Introduction: Michael B Tollefson is a distinguished inventor based in O'Fallon, Missouri, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Michael B Tollefson holds several patents in the areas of software development, artificial intelligence, and renewable energy technologies, showcasing his versatility and forward-thinking approach.

Career Highlights: With over two decades of experience in the industry, Michael has worked with leading tech companies to develop cutting-edge solutions that have revolutionized the way we interact with technology on a daily basis.

Collaborations: Throughout his career, Michael has collaborated with top researchers, engineers, and developers to bring his ideas to life, fostering a culture of innovation and creativity in the teams he works with.

Conclusion: Michael B Tollefson's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of technology, with a lasting impact on the industry as a whole.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…